Influence of antimuscarinic therapy on cognitive functions and quality of life in geriatric patients treated for overactive bladder

References

• Abrams, P., Andersson, K., Buccafusco, J., Chapple, C., de Groat, W.C., Fryer, A.D., … Wein, A.J. (2006). Muscarinic receptors: Their distribution and function in body systems, and the implications for treating overactive bladder. British Journal of Pharmacology, 148, 565–578.
   PubMed Web of Science ®Google Scholar
• Abrams, P., Cardozo, L., Fall, M., Griffiths, D., Rosier, P., Ulmsten, U., … Standardisation Sub-committee of the International Continence Society. (2002). The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society. Neurourology and Urodynamics, 21, 167–178.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association and the National Kidney Foundation. (1994). Consensus development conference on the diagnosis and management of nephropathy in patients with diabetes mellitus. Diabetes Care, 17, 1357–1361.
   PubMed Web of Science ®Google Scholar
• Black, S.A., Goodwin, J.S., & Markides, K.S. (1998). The association between chronic diseases and depressive symptomatology in older Mexican Americans. Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 53, M188–M194.
   PubMed Web of Science ®Google Scholar
• Brown, J.S., Vittinghoff, E., Wyman, J.F., Stone, K.L., Nevitt, M.C., Ensrud, K.E., & Grady, D. (2000). Urinary incontinence: Does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group. Journal of the American Geriatrics Society, 48, 721–725.
   PubMed Web of Science ®Google Scholar
• Burkhardt, H., Zorn, H.M., Pieper, K., Gray, M., & Steers, W. (1999). Urinary incontinence and depression. The Journal of Urology, 162, 82–84.
   PubMed Web of Science ®Google Scholar
• Campbell, A.J., Reinken, J., & McCosh, L. (1985). Incontinence in the elderly: Prevalence and prognosis. Age and Ageing, 14, 65–70.
   PubMed Web of Science ®Google Scholar
• Cardozo, L., Khullar, V., Wang, J., Guan, Z., & Sand, P.K. (2010). Fesoterodine in patients with overactive bladder syndrome: Can the severity of baseline urgency urinary incontinence predict dosing requirement? BJU International, 106, 816–821.
   PubMed Web of Science ®Google Scholar
• Chancellor, M., & Boone, T. (2012). Anticholinergics for overactive bladder therapy: Central nervous system effects. CNS Neuroscience & Therapeutics, 18, 167–174.
   PubMed Web of Science ®Google Scholar
• Chapple, C.R., Khullar, V., Gabriel, Z., Muston, D., Bitoun, C.E., & Weinstein, D. (2008). The effects of antimuscarinic treatments in overactive bladder: An update of a systematic review and meta-analysis. European Urology, 54, 543–562.
   PubMed Web of Science ®Google Scholar
• Cigolle, C., Langa, K., Kabeto, M., Tian, Z., & Blaum, C.S. (2007). Geriatric conditions and disability: The Health and Retirement Study. Annals of Internal Medicine, 147, 156–164.
   PubMed Web of Science ®Google Scholar
• Del-Ser, T., Munoz, D., & Hachinski, V. (1996). Temporal pattern of cognitive decline and incontinence is different in Alzheimer's disease and diffuse Lewy body disease. Neurology, 46, 682–686.
   PubMed Web of Science ®Google Scholar
• Fauci, A.S. (2008) Harrison's principles of internal medicine (17th ed.). New York, NY: McGraw-Hill.
   Google Scholar
• Feinberg, M. (1993). The problems of anticholinergic adverse effects in older patients. Drugs & Aging, 3, 335–348.
   PubMed Web of Science ®Google Scholar
• Francis, P.T., Palmer, A.M., Snape, M., & Wilcock, G.K. (1999). The cholinergic hypothesis of Alzheimer's disease: A review of progress. Journal of Neurology, Neurosurgery & Psychiatry, 66, 137–147.
   PubMed Web of Science ®Google Scholar
• Heymen, S. (2004). Psychological and cognitive variables affecting treatment outcomes for urinary and fecal incontinence. Gastroenterology, 126, S146–S151.
   Google Scholar
• Jackson, S., Scholes, D., Boyko, E., Abraham, L., & Fihn, S.D. (2006). Predictors of urinary incontinence in a prospective cohort of postmenopausal women. Obstetrics & Gynecology, 108, 855–862.
   PubMed Web of Science ®Google Scholar
• Jewart, R.D., Green, J., Lu, C.J., Cellar, J., & Tune, L.E. (2005). Cognitive, behavioral, and physiological changes in Alzheimer disease patients as a function of incontinence medications. American Journal of Geriatric Psychiatry, 13, 324–328.
   PubMed Web of Science ®Google Scholar
• Jumadilova, Z., Varadharajan, S., Girase, P., & Ollendorf, D.A. (2006). Retrospective evaluation of outcomes in patients with overactive bladder receiving tolterodine versus oxybutynin. American Journal of Health-System Pharmacy, 63, 2357–2364.
   PubMed Web of Science ®Google Scholar
• Kay, G., Abou-Donia, M., Messer, W.J., Murphy, D.G., Tsao, J.W., & Ouslander, J.G. (2005). Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients. Journal of the American Geriatrics Society, 53, 2195–2201.
   PubMed Web of Science ®Google Scholar
• Kay, G., Crook, T., Rekeda, L., Lima, R., Ebinger, U., Arguinzoniz, M., & Steel, M. (2006). Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects. European Urology, 50, 317–326.
   PubMed Web of Science ®Google Scholar
• Kay, G., & Granville, L. (2005). Antimuscarinic agents: Implications and concerns in the management of overactive bladder in the elderly. Clinical Therapeutics, 27, 127–138; quiz 139–140.
   PubMed Web of Science ®Google Scholar
• Kay, G., & Wesnes, K. (2005). Pharmacodynamic effects of darifenacin, a muscarinic M selective receptor antagonist for the treatment of overactive bladder, in healthy volunteers. BJU International, 96, 1055–1062.
   PubMed Web of Science ®Google Scholar
• Levin, R.M., Juan, Y.S., Whitback, C., Perez-Martinez, F.C., & Lin, W.Y. (2008). The effect of darifenacin on overactive bladders in female and male rabbits. International Urology and Nephrology, 40, 303–309.
   PubMed Web of Science ®Google Scholar
• Maggi, S., Minicuci, N., Langlois, J., Pavan, M., Enzi, G., & Crepaldi, G. (2001). Prevalence rate of urinary incontinence in community-dwelling elderly individuals: The Veneto study. Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 56, M14–M18.
   PubMed Web of Science ®Google Scholar
• Matsumoto, Y., Miyazato, M., Furuta, A., Torimoto, K., Hirao, Y., Chancellor, M.B., & Yoshimura, N. (2010). Differential roles of M2 and M3 muscarinic receptor subtypes in modulation of bladder afferent activity in rats. Urology, 75, 862–867.
   PubMed Web of Science ®Google Scholar
• Meek, P.D., Evang, S.D., Tadrous, M., Roux-Lirange, D., Triller, D.M., & Gumustop, B. (2011). Overactive bladder drugs and constipation: A meta-analysis of randomized, placebo-controlled trials. Digestive Diseases and Sciences, 56, 7–18.
   PubMed Web of Science ®Google Scholar
• Melville, J., Delaney, K., Newton, K., & Katon, W. (2005). Incontinence severity and major depression in incontinent women. Obstetrics & Gynecology, 106, 585–592.
   PubMed Web of Science ®Google Scholar
• Melville, J.L., Fan, M.Y., Rau, H., Nygaard, I.E., & Katon, W.J. (2009) Major depression and urinary incontinence in women: Temporal associations in an epidemiologic sample. American Journal of Obstetrics & Gynecology, 201, 490.e1–490.e7.
   Google Scholar
• Melville, J.L., Walker, E., Katon, W., Lentz, G., Miller, J., & Fenner, D. (2002). Prevalence of comorbid psychiatric illness and its impact on symptom perception, quality of life, and functional status in women with urinary incontinence. American Journal of Obstetrics & Gynecology, 187, 80–87.
   PubMed Web of Science ®Google Scholar
• Merchant, R., Li, B., Yap, K., Li, B., Yap, K.-B., & Ng, T.-P. (2009). Use of drugs with anticholinergic effects and cognitive impairment in community-living older persons. Age and Ageing, 38, 105–108.
   PubMed Web of Science ®Google Scholar
• Moghaddas, F., Lidfeldt, J., Nerbrand, C., Jernström, H., & Samsioe, G. (2005). Prevalence of urinary incontinence in relation to self-reported depression, intake of serotonergic antidepressants, and hormone therapy in middle-aged women: A report from the Women's Health in the Lund Area study. Menopause, 12, 318–324.
   PubMed Web of Science ®Google Scholar
• Monz, B., Chartier-Kastler, E., Hampel, C., Samsioe, G., Hunskaar, S., Espuna-Pons, M., … Chinn, C., (2007). Patient characteristics associated with quality of life in European women seeking treatment for urinary incontinence: Results from PURE. European Urology, 51, 1073–1081; discussion 1081–1082.
   PubMed Web of Science ®Google Scholar
• Nuotio, M., Jylhä, M., Luukkaala, T., & Tammela, T.L. (2003). Urinary incontinence in a Finnish population aged 70 and over. Prevalence of types, associated factors and self-reported treatments. Scandinavian Journal of Primary Health Care, 21, 182–187.
   PubMed Web of Science ®Google Scholar
• Nygaard, I., Turvey, C., Burns, T., Crischilles, E., & Wallace, R. (2003). Urinary incontinence and depression in middle-aged United States women. Obstetrics & Gynecology, 101, 149–156.
   PubMed Web of Science ®Google Scholar
• Oefelein, M.G. (2011). Safety and tolerability profiles of anticholinergic agents used for the treatment of overactive bladder. Drug Safety, 34, 733–754.
   PubMed Web of Science ®Google Scholar
• Ozerdoğan, N., Beji, N., & Yalçin, O. (2004). Urinary incontinence: Its prevalence, risk factors and effects on the quality of life of women living in a region of Turkey. Gynecologic and Obstetric Investigation, 58, 145–150.
   PubMed Web of Science ®Google Scholar
• Seeger, T., Fedorova, I., Zheng, F., Miyakawa, T., Koustova, E., Gomeza, J., … Wess, J. (2004). M2 muscarinic acetylcholine receptor knock-out mice show deficits in behavioral flexibility, working memory, and hippocampal plasticity. Journal of Neuroscience, 24, 10117–10127.
   PubMed Web of Science ®Google Scholar
• Skelly, J., & Flint, A.J. (1995). Urinary incontinence associated with dementia. Journal of the American Geriatrics Society, 43, 286–294.
   PubMed Web of Science ®Google Scholar
• Stach-Lempinen, B., Hakala, A.L., Laippala, P., Lehtinen, K., Metsänoja, R., & Kujansuu, E. (2003). Severe depression determines quality of life in urinary incontinent women. Neurourology and Urodynamics, 22, 563–568.
   PubMed Web of Science ®Google Scholar
• Staskin, D., Kay, G., Tannenbaum, C., Goldman, H.B., Bhashi, K., Ling, J., & Oefelein, M.G. (2010). Trospium chloride is undetectable in the older human central nervous system. Journal of the American Geriatrics Society, 58, 1618–1619.
   PubMed Web of Science ®Google Scholar
• Staskin, D.R., & Zoltan, E. (2007). Anticholinergics and central nervous system effects: Are we confused? Reviews in Urology, 9, 191–196.
   PubMedGoogle Scholar
• Stewart, W.F., Van Rooyen, J.B., Cundiff, G.W., Abrams, P., Herzog, A.R., Corey, R., … Wein, A.J. (2003). Prevalence and burden of overactive bladder in the United States. World Journal of Urology, 20, 327–336.
   PubMed Web of Science ®Google Scholar
• Tiwari, A., & Naruganahalli, K.S. (2006). Current and emerging investigational medical therapies for the treatment of overactive bladder. Expert Opinion on Investigational Drugs, 15, 1017–1037.
   PubMed Web of Science ®Google Scholar
• Van Oyen, H., & Van Oyen, P. (2002). Urinary incontinence in Belgium; prevalence, correlates and psychosocial consequences. Acta Clinica Belgica, 57, 207–218.
   PubMed Web of Science ®Google Scholar
• Varli, M., Aras, S., & Atli, T. (2009). Urinary incontinence and treatment in the elderly. The Journal of Academic Geriatrics, 1, 45–58.
   Google Scholar
• Waetjen, L., Liao, S., Johnson, W., Sampselle, C.M., Sternfield, B., Harlow, S.D., & Gold, E.B. (2007). Factors associated with prevalent and incident urinary incontinence in a cohort of midlife women: A longitudinal analysis of data: Study of women's health across the nation. American Journal of Epidemiology, 165, 309–318.
   PubMed Web of Science ®Google Scholar
• Wagg, A. (2012). The cognitive burden of anticholinergics in the elderly – implications for the treatment of overactive bladder. European Urology Review, 7(1), 42–49.
   Google Scholar
• Wagg, A., Verdejo, C., & Molander, U. (2010). Review of cognitive impairment with antimuscarinic agents in elderly patients with overactive bladder. International Journal of Clinical Practice, 64(9), 1279–1286.
   PubMed Web of Science ®Google Scholar
• Yap, P., & Tan, D. (2006). Urinary incontinence in dementia – a practical approach. Australian Family Physician, 35, 237–241.
   PubMedGoogle Scholar
• Yoshida, A., Maruyama, S., Fukumoto, D., Tsukada, H., Ito, Y., & Yamada, S. (2010). Noninvasive evaluation of brain muscarinic receptor occupancy of oxybutynin, darifenacin and imidafenacin in rats by positron emission tomography. Life Science, 87, 175–180.
   PubMed Web of Science ®Google Scholar